ImmunoGen
IMGN
#1832
Rank
$8.72 B
Marketcap
$31.23
Share price
0.00%
Change (1 day)
134.11%
Change (1 year)

Revenue for ImmunoGen (IMGN)

Revenue in 2023 (TTM): $0.28 Billion USD

According to ImmunoGen 's latest financial reports the company's current revenue (TTM ) is $0.28 Billion USD. In 2022 the company made a revenue of $0.10 Billion USD an increase over the revenue in the year 2021 that were of $69.85 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunoGen from 1996 to 2023

20002005201020152020$50M$0.1B$0.15B$0.2B$0.25B$0.3Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2023 (TTM) $0.28 B164.39%
2022 $0.10 B55.72%
2021 $69.85 M-47.2%
2020 $0.13 B60.81%
2019 $82.27 M53.93%
2018 $53.44 M-53.71%
2017 $0.11 B
2015 $56.91 M-23.21%
2014 $74.12 M-2.61%
2013 $76.11 M489.68%
2012 $12.9 M-40.98%
2011 $21.86 M42.7%
2010 $15.32 M-18.2%
2009 $18.73 M-45.75%
2008 $34.53 M-12.68%
2007 $39.54 M5.27%
2006 $37.56 M17.28%
2005 $32.02 M-8.37%
2004 $34.95 M194.75%
2003 $11.85 M53.32%
2002 $7.73 M44.88%
2001 $5.33 M-29.78%
2000 $7.6 M-23.2%
1999 $9.9 M890%
1998 $1 M150%
1997 $0.4 M0%
1996 $0.4 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$2.30 B 699.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$33.42 B 11,521.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$45.04 B 15,560.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$48.30 B 16,693.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$88.82 B 30,782.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.62 B 22,022.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.72 B 17,883.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$47.96 B 16,575.25%๐Ÿ‡ซ๐Ÿ‡ท France